Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Int J Infect Dis ; 113 Suppl 1: S68-S72, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33713812

RESUMO

Despite slow reductions in the annual burden of active human tuberculosis (TB) cases, zoonotic TB (zTB) remains a poorly monitored and an important unaddressed global problem. There is a higher incidence in some regions and countries, especially where close association exists between growing numbers of cattle (the major source of Mycobacterium bovis) and people, many suffering from poverty, and where dairy products are consumed unpasteurised. More attention needs to be focused on possible increased zTB incidence resulting from growth in dairy production globally and increased demand in low income countries in particular. Evidence of new zoonotic mycobacterial strains in South Asia and Africa (e.g. M. orygis), warrants urgent assessment of prevalence, potential drivers and risk in order to develop appropriate interventions. Control of M. bovis infection in cattle through detect and cull policies remain the mainstay of reducing zTB risk, whilst in certain circumstances animal vaccination is proving beneficial. New point of care diagnostics will help to detect animal infections and human cases. Given the high burden of human tuberculosis (caused by M. tuberculosis) in endemic areas, animals are affected by reverse zoonosis, including multi-drug resistant strains. This, may create drug resistant reservoirs of infection in animals. Like COVID-19, zTB is evolving in an ever-changing global landscape.


Assuntos
COVID-19 , Tuberculose , África , Animais , Bovinos , Humanos , Políticas , SARS-CoV-2 , Tuberculose/diagnóstico , Tuberculose/epidemiologia , Tuberculose/prevenção & controle
3.
Trans R Soc Trop Med Hyg ; 115(1): 117-119, 2021 01 07.
Artigo em Inglês | MEDLINE | ID: mdl-33031556

RESUMO

With lockdown restrictions over coronavirus disease 2019 being relaxed, airlines are returning to the skies. Published evidence of severe acute respiratory syndrome (SARS) coronavirus 2 transmission on aircraft is limited, but in-flight transmission of respiratory infections such as tuberculosis, influenza and SARS has been well described. Risk factors include proximity to index patients and sitting in aisle seats. Personal protection on aircraft could be enhanced by always wearing a well-fitting face mask and face shield or sunglasses, wiping surfaces and hands with alcohol-based sanitizers, not touching the face, not queuing for washrooms, changing seats if nearby passengers are coughing and choosing a window rather than an aisle seat.


Assuntos
Viagem Aérea , Aeronaves , COVID-19/prevenção & controle , Controle de Doenças Transmissíveis/métodos , Pandemias , SARS-CoV-2 , COVID-19/epidemiologia , COVID-19/transmissão , COVID-19/virologia , Tosse , Desinfecção , Óculos , Higienizadores de Mão , Humanos , Máscaras , Distanciamento Físico , Fatores de Risco , Tato
4.
Int J Infect Dis ; 92S: S51-S54, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-32114202

RESUMO

Tuberculosis (TB) remains a major public health threat. In 2018, an estimated 10 million people fell ill with TB and 1.5 million died of the disease. The End TB Strategy envisages an end to TB as a public health threat and has set ambitious targets to reduce TB incidence and mortality by 90% and 95%, respectively, by 2035 compared with 2015. In this paper we describe the progress that is being made towards the achievement of these targets and highlight the challenges that are hampering this progress. The development and deployment of new tools will certainly accelerate progress towards ending TB. We believe that the end of TB is realizable if there are sustained efforts to actively find TB cases, a more robust multi-sectoral approach to tackle social determinants of TB, and improved person-centred health services.


Assuntos
Tuberculose/tratamento farmacológico , Humanos , Incidência , Tuberculose/epidemiologia , Tuberculose/prevenção & controle
6.
Ann Am Thorac Soc ; 12(4): 486-90, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25714500

RESUMO

It is estimated that 85% of the world's population lives in low- and middle-income countries (LMICs). Although economic conditions are improving in these countries, health expenditures have not kept pace with the overall economic growth, and health systems remain weak. These already inadequate systems are being further stressed by the epidemiologic transition that is taking place, characterized by a slow decrease in communicable diseases and an increase in noninfectious chronic diseases, resulting in a "double burden" of infectious and noninfectious diseases. Respiratory diseases comprise the largest category of illness within this combined burden of disease. Although there are chronic respiratory disease programs of proven effectiveness appropriate for LMICs, implementation has been greatly hampered by the lack of physicians who have special knowledge and skills in addressing the full spectrum of lung diseases. Thus, there is an urgent need to create training programs for specialists in respiratory diseases. Such programs should be developed and conducted by institutions in LMICs and tailored to fit the prevailing circumstances of the country. Existing curriculum blueprints may be used to guide training program development with appropriate modifications. Academic institutions and professional societies in high-income countries may be called upon to provide technical assistance in developing and implementing training programs. In order to better define the burden of respiratory diseases and identify effective interventions, research, moved forward by persons committed and specialized in this area of health, will be essential.


Assuntos
Países em Desenvolvimento , Bolsas de Estudo/métodos , Necessidades e Demandas de Serviços de Saúde , Pneumologia/educação , Doenças Respiratórias/epidemiologia , Bolsas de Estudo/estatística & dados numéricos , Humanos , Desenvolvimento de Programas , Melhoria de Qualidade , Doenças Respiratórias/terapia , Recursos Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...